Recurrent Ovarian Cancer: Use of Contrast-enhanced CT and PET/CT to Accurately Localize Tumor Recurrence and to Predict Patients’ Survival-Reference-Cited by-同舟云学术

Recurrent Ovarian Cancer: Use of Contrast-enhanced CT and PET/CT to Accurately Localize Tumor Recurrence and to Predict Patients’ Survival

Published:2010-10 Issue:1 Volume:257 Page:125-134
ISSN:0033-8419
Container-title:Radiology
language:en
Short-container-title:Radiology

Author:

Sala Evis,Kataoka Masako,Pandit-Taskar Neeta,Ishill Nicole,Mironov Svetlana,Moskowitz Chaya S.,Mironov Oleg,Collins Michelle A.,Chi Dennis S.,Larson Steven,Hricak Hedvig

Publisher

Radiological Society of North America (RSNA)

Subject

Radiology, Nuclear Medicine and imaging

Link

http://pubs.rsna.org/doi/pdf/10.1148/radiol.10092279

Reference31 articles.

1. Cancer Statistics, 2009

2. Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience.

3. Monitoring Cancer Antigen 125 Levels in Induction Chemotherapy for Epithelial Ovarian Carcinoma and Predicting Outcome of Second-Look Procedure

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 18FDG-PET/CT versus Contrast Enhanced CT in detection of mucinous ovarian cancer recurrence: comparative study;2024-02-20

2. 18F-FDG PET/MRI and 18F-FDG PET/CT for the Management of Gynecological Malignancies: A Comprehensive Review of the Literature;Journal of Imaging;2023-10-13

3. The role of PET/CT with fluorine-18-deoxyglucose in the detection of relapsed serous ovarian cancer in patients with normal serum CA125 levels;Ginekologia Polska;2023-09-01

4. A preoperative nomogram incorporating CT to predict the probability of ovarian clear cell carcinoma;Gynecologic Oncology;2023-09

5. Efficiency of whole-body positron emission tomography/computed tomography using 18F-Fluorodeoxyglucose in detecting the cause of elevated cancer antigen 125 serum level in treated ovarian cancer patients;Egyptian Journal of Radiology and Nuclear Medicine;2023-07-18